ABCL
Price
$4.22
Change
+$0.06 (+1.44%)
Updated
Sep 5 closing price
Capitalization
1.26B
66 days until earnings call
CING
Price
$3.90
Change
+$0.11 (+2.90%)
Updated
Sep 5 closing price
Capitalization
21.11M
Interact to see
Advertisement

ABCL vs CING

Header iconABCL vs CING Comparison
Open Charts ABCL vs CINGBanner chart's image
AbCellera Biologics
Price$4.22
Change+$0.06 (+1.44%)
Volume$4.17M
Capitalization1.26B
Cingulate
Price$3.90
Change+$0.11 (+2.90%)
Volume$147.07K
Capitalization21.11M
ABCL vs CING Comparison Chart in %
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CING
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. CING commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and CING is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ABCL: $4.22 vs. CING: $3.90)
Brand notoriety: ABCL and CING are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 78% vs. CING: 105%
Market capitalization -- ABCL: $1.26B vs. CING: $21.11M
ABCL [@Biotechnology] is valued at $1.26B. CING’s [@Biotechnology] market capitalization is $21.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileCING’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • CING’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than CING.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 2 TA indicator(s) are bullish while CING’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 2 bullish, 4 bearish.
  • CING’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both ABCL and CING are a bad buy in the short-term.

Price Growth

ABCL (@Biotechnology) experienced а +0.96% price change this week, while CING (@Biotechnology) price change was -2.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

ABCL is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.26B) has a higher market cap than CING($21.1M). ABCL YTD gains are higher at: 44.027 vs. CING (-20.892). CING has higher annual earnings (EBITDA): -15.75M vs. ABCL (-197.92M). ABCL has more cash in the bank: 553M vs. CING (9.52M). CING has less debt than ABCL: CING (5.08M) vs ABCL (142M). ABCL has higher revenues than CING: ABCL (32.9M) vs CING (0).
ABCLCINGABCL / CING
Capitalization1.26B21.1M5,976%
EBITDA-197.92M-15.75M1,257%
Gain YTD44.027-20.892-211%
P/E RatioN/A0.03-
Revenue32.9M0-
Total Cash553M9.52M5,809%
Total Debt142M5.08M2,794%
TECHNICAL ANALYSIS
Technical Analysis
ABCLCING
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CING
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MNDJX30.400.29
+0.96%
MFS New Discovery R4
JAIGX51.760.39
+0.76%
Janus Henderson VIT Overseas Instl
MDISX33.630.03
+0.09%
Franklin Mutual Global Discovery Z
RYIIX170.83N/A
N/A
Rydex Internet Inv
IJMAX13.53-0.01
-0.07%
VY® JPMorgan Mid Cap Value A

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+1.44%
CRSP - ABCL
58%
Loosely correlated
+4.02%
RXRX - ABCL
57%
Loosely correlated
+1.99%
ABSI - ABCL
54%
Loosely correlated
+2.50%
NTLA - ABCL
51%
Loosely correlated
+3.79%
BEAM - ABCL
51%
Loosely correlated
+12.62%
More

CING and

Correlation & Price change

A.I.dvisor indicates that over the last year, CING has been loosely correlated with ABCL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CING jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CING
1D Price
Change %
CING100%
+2.90%
ABCL - CING
34%
Loosely correlated
+1.44%
XRTX - CING
28%
Poorly correlated
+1.85%
BEIGF - CING
28%
Poorly correlated
N/A
LQDA - CING
26%
Poorly correlated
+0.03%
BIXT - CING
26%
Poorly correlated
+1.36%
More